Screening for atrial fibrillation
36 results
1 - 36
Screening for atrial fibrillation in primary care is not effective (VITAL-AF)- USPSTF 2022 concludes evidence is insufficient to recommend screening for asymptomatic atrial fibrillation (I statement)
- Screening high-risk patients for atrial fibrillation with implantable loop recorder does not prevent stroke or systemic emboli (LOOP)
- Automated devices detect only 67% to 83% of patients with atrial fibrillation
- USPSTF 2018: insufficient evidence to recommend screening for AFib with ECG (I statement)
- The prognosis is similar for adults with symptomatic versus asymptomatic atrial fibrillation
- ACC/AHA guidelines for the diagnosis and management of atrial fibrillation
- Lower risk of atrial fibrillation with addition of vasopressin to catecholamines for treatment of shock
- Intensive cardiovascular screening has little benefit in older men (DANCAVAS)
- AHA guideline for secondary stroke prevention
- Low-intensity warfarin may be inferior to standard-intensity warfarin for preventing VTE after joint arthroplasty
- Zoledronic acid reduces asymptomatic fractures but not clinical ones in men
- Empagliflozin reduces hospitalization for heart failure with preserved ejection fraction (NNT = 59 per year), but not mortality outcomes (EMPEROR-Preserved)